SEC Form 4 · accession 0001179110-15-009306
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Ivan Law
Officer — Principal Accounting Officer
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2015 | P | 100 | $18.83 | A | 100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $13.05 | holding | — | — | — | Nov 17, 2014 | Nov 17, 2024 | Common Stock | 20,000 | 20,000 | D |